Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sage Therapeutic Com
(NQ:
SAGE
)
8.090
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
8.090
Bid (Size)
7.320 (20)
Ask (Size)
9.690 (6)
Prev. Close
8.090
Today's Range
8.090 - 8.090
52wk Range
7.700 - 28.26
Shares Outstanding
59,762,106
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SAGE THERAPEUTICS, INC. (NASDAQ: SAGE) INVESTOR ALERT: Investors With Large Losses in Sage Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
Today 1:45 EDT
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against Sage Therapeutics, Inc.
August 29, 2024
From
Robbins LLP
Via
GlobeNewswire
Performance
YTD
-64.01%
-64.01%
1 Month
-25.09%
-25.09%
3 Month
-29.65%
-29.65%
6 Month
-62.34%
-62.34%
1 Year
-58.98%
-58.98%
More News
Read More
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
August 29, 2024
From
The Schall Law Firm
Via
Business Wire
Expert Outlook: Sage Therapeutics Through The Eyes Of 14 Analysts
July 30, 2024
Via
Benzinga
Analyst Expectations For Sage Therapeutics's Future
July 12, 2024
Via
Benzinga
Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 04, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Sage Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
July 31, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
July 26, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
19 Analysts Have This To Say About Sage Therapeutics
June 20, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics
May 29, 2024
Via
Benzinga
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 24, 2024
Via
Benzinga
Sage, Biogen Shelve Development Of Nervous System Disorder Drug After Data Disappoints
July 24, 2024
Via
Benzinga
Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails
July 24, 2024
Via
Investor's Business Daily
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 24, 2024
Via
InvestorPlace
Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor
July 24, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Netflix To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Friday
July 19, 2024
Via
Benzinga
Sage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024
July 17, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Delta Air Lines Posts Downbeat Earnings, Joins United Airlines, American Airlines And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
July 11, 2024
Via
Benzinga
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 12, 2024
Via
Benzinga
Sage Therapeutics Reports Phase 2 Huntington's Data
June 11, 2024
Via
Benzinga
Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease
June 11, 2024
From
Sage Therapeutics
Via
Business Wire
Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Wall Street's Top 10 Stock Calls This Week - Sunday, June 2
June 02, 2024
Via
Talk Markets
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
May 21, 2024
Via
Benzinga
Sage Therapeutics to Participate in Upcoming May Investor Conferences
May 07, 2024
From
Sage Therapeutics
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.